1. Lam, A, Goulouti, E, Roten, L (2017) The search for atrial fibrillation and its impact on public health. Swiss medical weekly 147: w14447.
Google Scholar | Medline2. Heeringa, J , et al. (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27(8): 949–953.
Google Scholar | Crossref | Medline | ISI3. Aggarwal, N , et al. (2015) Atrial fibrillation in the young: a neurologist's nightmare. Neurol Res Int 2015: 374352.
Google Scholar | Crossref | Medline4. Sankaranarayanan, R , et al. (2013) Comparison of atrial fibrillation in the young versus that in the elderly: a review. Cardiol Res Pract 2013: 976976.
Google Scholar | Crossref | Medline5. Chamberlain, AM , et al. (2011) Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm 8(8): 1160–1166.
Google Scholar | Crossref | Medline6. Pignatelli, P , et al. (2015) Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. Europace 17(8): 1223–1228.
Google Scholar | Crossref | Medline7. Germaine, S , et al. (2012) The influence of cigarette smoking on endothelial function. J Food Agric Environ 10(1): 25–28.
Google Scholar8. Balint, GS, Borza, C, Cristescu, C, Andoni, M, Simu, GM, Malita, D, et al (2011) Endogenous and exogenous antioxidant protection for endothelial dysfunction. Rev Chim (Bucharest) 62: 680–683.
Google Scholar9. Weijs, B, Schotten, U, Crijns, HJ (2015) Pathophysiology of idiopathic atrial fibrillation-prognostic and treatment implications. Curr Pharmaceut Des 21(5): 551–572.
Google Scholar | Crossref | Medline10. Bansal, N , et al. (2013) Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 127(5): 569–574.
Google Scholar | Crossref | Medline11. Conen, D , et al. (2011) Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. Jama 305(20): 2080–2087.
Google Scholar | Crossref | Medline12. Kalantarian, S , et al. (2013) Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 158(5 Pt 1): 338–346.
Google Scholar | Crossref | Medline13. O'Neal, WT , et al. (2015) Atrial fibrillation and incident end-stage renal disease: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Int J Cardiol 185: 219–223.
Google Scholar | Crossref | Medline14. Anderson, EJ , et al. (2014) Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation. J Am Heart Assoc 3(1): e000713.
Google Scholar | Crossref | Medline15. Muntean, DM , et al. (2016) The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies. Oxid Med Cell Longev, 2016: 8254942.
Google Scholar | Crossref | Medline | ISI16. Duicu, OM , et al. (2016) Assessment of mitochondrial dysfunction and monoamine oxidase contribution to oxidative stress in human diabetic hearts. Oxid Med Cell Longev 2016: 8470394.
Google Scholar | Crossref | Medline17. Odutayo, A , et al. (2016) Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. Br Med J 354: i4482.
Google Scholar | Crossref | Medline18. Hahne, K, Mönnig, G, Samol, A (2016) Atrial fibrillation and silent stroke: links, risks, and challenges. Vasc Health Risk Manag 12: 65–74.
Google Scholar | Medline19. Maris, MI , et al. (2019) Are inherited combined thrombophilia mutations a causative or an additive factor in recurrent venous thrombotic accidents? Clin Lab 1–65.
Google Scholar20. Andrew, NE, Thrift, AG, Cadilhac, DA (2013) The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?. Neuroepidemiology 40(4): 227–239.
Google Scholar | Crossref | Medline21. Hannon, N , et al. (2010) Stroke associated with atrial fibrillation--incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 29(1): 43–49.
Google Scholar | Crossref | Medline22. Kalantarian, S , et al. (2014) Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis. Ann Intern Med 161(9): 650–658.
Google Scholar | Crossref | Medline23. Mahesh, PKB , et al. (2020) Post-stroke quality of life index: a quality of life tool for stroke survivors from Sri Lanka. Health Qual Life Outcomes 18(1): 239.
Google Scholar | Crossref | Medline24. Spertus, J , et al. (2011) Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 4(1): 15–25.
Google Scholar | Crossref | Medline | ISI25. Aliot, E , et al. (2014) Quality of life in patients with atrial fibrillation: how to assess it and how to improve it. Europace 16(6): 787–796.
Google Scholar | Crossref | Medline26. Zamani, P, Verdino, RJ (2015) Management of Atrial Fibrillation. J Intensive Care Med 30(8): 484–498.
Google Scholar | SAGE Journals | ISI27. Wyse, DG , et al. (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347(23): 1825–1833.
Google Scholar | Crossref | Medline | ISI28. Van Gelder, IC , et al. (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347(23): 1834–1840.
Google Scholar | Crossref | Medline | ISI29. Gutierrez, C, Blanchard, DG (2016) Diagnosis and treatment of atrial fibrillation. Am Fam Physician 94(6): 442–452.
Google Scholar | Medline30. Westerman, S, Wenger, N (2019) Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev 15(2): 136–144.
Google Scholar | Crossref | Medline31. Kundnani, NR , et al. (2021) Selecting the right anticoagulant for stroke prevention in atrial fibrillation. Eur Rev Med Pharmacol Sci 25(13): 4499–4505.
Google Scholar | Medline32. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med, 1997. 336(8): p. 525-533.
Google Scholar | Crossref | Medline | ISI33. Wang, ZQ , et al. (2015) Digoxin is associated with increased all-cause mortality in patients with atrial fibrillation regardless of concomitant heart failure: a meta-analysis. J Cardiovasc Pharmacol 66(3): 270–275.
Google Scholar | Crossref | Medline | ISI34. Kühlkamp, V , et al. (2002) Use of beta-blockers in atrial fibrillation. Am J Cardiovasc Drugs 2(1): 37–42.
Google Scholar | Crossref | Medline35. Scalese, MJ, Salvatore, DJ (2017) Role of digoxin in atrial fibrillation. J Pharm Pract 30(4): 434–440.
Google Scholar | SAGE Journals36. Fauchier, L , et al. (2016) Beta-blockers or digoxin for atrial fibrillation and heart failure? Card Fail Rev 2(1): 35–39.
Google Scholar | Crossref | Medline37. Washam, JB , et al. (2015) Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Lancet 385(9985): 2363–2370.
Google Scholar | Medline38. Kirchhof, P , et al. (2016) A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace 18(1): 37–50.
Google Scholar | Crossref | Medline39. Kotecha, D , et al. (2017) A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial. BMJ Open. 7(7): e015099.
Google Scholar | Crossref | Medline40. Atrial fibrillation: management. NICE, 180. http://www.nice.org.uk/guidance/cg180/.
Google Scholar41. Kirchhof, P , et al. (2016) ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 50(5): e1–e88.
Google Scholar | Crossref | Medline42. Lip, GY , et al. (2014) A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 16(3): 308–319.
Google Scholar | Crossref | Medline43. Nabauer, M , et al. (2009) The registry of the german competence network on atrial fibrillation: patient characteristics and initial management. Europace 11(4): 423–434.
Google Scholar | Crossref | Medline | ISI44. Steg, PG , et al. (2012) Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart 98(3): 195–201.
Google Scholar | Crossref | Medline | ISI45. January, CT , et al. (2014) AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 64(21): e1–76.
Google Scholar | Crossref | Medline | ISI46. Segal, JB , et al. (2000) The evidence regarding the drugs used for ventricular rate control. J Fam Pract 49(1): 47–59.
Google Scholar | Medline47. Kotecha, D , et al. (2014) Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384(9961): 2235–2243.
Google Scholar | Crossref | Medline | ISI48. Ziff, OJ , et al. (2015) Safety and efficacy of Digoxin: Systematic Review and Meta-Analysis of Observational and Controlled Trial Data, 351, p. h4451.
Google Scholar49. Khand, AU , et al. (2003) Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 42(11): 1944–1951.
Google Scholar | Crossref | Medline50. Al-Khatib, SM , et al. (2014) Rate-and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med 160(11): 760–773.
Google Scholar | Crossref | Medline51. Chatterjee, S , et al. (2013) Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol 36(1): 122–133.
Google Scholar | Crossref | Medline52. de Denus, S , et al. (2005) Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 165(3): 258–262.